Clinician Responses to Pediatric Lipid Screens Suggestive of Severe Dyslipidemia

OBJECTIVES: To measure case detection and response time of severe pediatric dyslipidemia, defined as non-high-density lipoprotein cholesterol (HDL-C) ≥190 mg/dL on the initial screening panel. Although low adherence to guidelines recommending universal pediatric lipid screening is well-documented, i...

Descripción completa

Detalles Bibliográficos
Autores principales: Zawacki, Amy W., Enright, Connor, Harris, Rachel E., Dodge, Ann, Peterson, Amy L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10236550/
https://www.ncbi.nlm.nih.gov/pubmed/37334253
http://dx.doi.org/10.1016/j.ympdx.2020.100037

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10236550/
https://www.ncbi.nlm.nih.gov/pubmed/37334253
http://dx.doi.org/10.1016/j.ympdx.2020.100037

Ejemplares similares